Heart cancer (primary cardiac tumor) is cancer that arises in the heart. Cancerous (malignant) tumors that begin in the heart are most often sarcomas, a type of cancer that originates in the soft tissues of the body. The vast majority of heart tumors are noncancerous (benign).
Heart cancer is extremely rare. For example, a review of more than 12,000 autopsies identified only seven cases of primary cardiac tumor — an incidence of less than 0.1 percent. At Mayo Clinic, on average only one case of heart cancer is seen each year.
Although still rare, most cancers found in the heart have come from elsewhere in the body. These include lymphomas that originate in the chest near the heart. Other cancers that can spread to the heart include melanomas and sarcomas.
Heart cancer may cause the following:
- Obstruction of blood flow through the heart
- Stiffening of the heart muscle (cardiac fibrosis)
- Interference with heart valves (marantic endocarditis)
In cases of marantic endocarditis, the heart valves are damaged by the cancer, and it may cause the valves to malfunction. In severe cases, the heart valves may need to be replaced. Unfortunately, this is often a sign of very advanced cancer and carries a poor prognosis. Another rare type of cancer known as carcinoid tumor at times produces hormones that can damage heart valves.
Cancer treatments also can affect the heart. Certain chemotherapy drugs can cause damage to the heart. Radiation therapy directed at or near the heart also can cause damage to the heart muscle and increase the risk of coronary artery disease later in life. Data also suggests that some hormonal cancer therapies may increase the risk of heart disease.
Apr. 12, 2012
See more Expert Answers
- Shick EC, et al. Cardiac tumors. http://www.uptodate.com/index. Accessed March 26, 2012.
- Bonow RO, et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.mdconsult.com/books/about.do?eid=4-u1.0-B978-1-4377-0398-6..C2009-0-59734-6--TOP&isbn=978-1-4377-0398-6&about=true&uniqId=236798031-10. Accessed March 26, 2012.
- Simpson L, et al. Malignant primary cardiac tumors: Review of a single institution experience. Cancer. 2008;112:2440.
- Amir E, et al. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: A systematic review and meta-analysis. Journal of the National Cancer Institute. 2011;103:1299.
- Moynihan TJ (expert opinion). Mayo Clinic, Rochester, Minn. March 26, 2012.